compounding semaglutide news today FDA Warns on Certain Forms of Compounded FDA moves to remove GLP-1

Imagine if the water in our taps were so toxic that pharma companies had to create a drug to make us not thirsty so we wouldn't drink the water that's kind of what's happening with these medications

doi: 10.1038/S41433-024-03101-5 83 JungBJLeeMYJeonS

Sattar N, Verma S, Sourij H, Wilson J, Stefanski A, Zhang X, Griffin R (2024) Inflammatory biomarkers in people treated with tirzepatide living with overweight or obesity, without and with T2D: a post-hoc analysis from SURMOUNT-1 and SURMOUNT-2

Is Semaglutide GLP-1 suitable for individuals with a BMI over 40

The primary patents extend through approximately 2032, though the exact date depends on potential patent extensions and legal challenges

Once applied, the patch uses a combination of permeation enhancers and micro-needles (depending on the technology) to deliver the medication through the outer layers of skin